drugset / Trial / NCT05679375
IV and Intrathecal Ketamine in Cesarean Section
NaParallel-groupTriple-blindPrevention
Summary
In the current study, the investigators will compare the effects of low-dose intravenous (i.v.) ketamine versus intrathecal Ketamine added to spinal anesthesia on the time to first request for analgesia and maternal pain scores and overall satisfaction in patients undergoing cesarean section.
Timeline
- Start
- 2023-02-01
- Primary completion
- 2024-10-31
- Completion
- 2024-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ketamine | Small molecule | 0.1 mg/kg | Intrathecal |
| Comparator | Ketamine | Small molecule | 0.25 mg/kg | Intrathecal |
Indications
No indication recorded.